UniProt ID | AVIL_HUMAN | |
---|---|---|
UniProt AC | O75366 | |
Protein Name | Advillin | |
Gene Name | AVIL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 819 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Cell projection. Cell projection, axon. | |
Protein Description | Ca(2+)-regulated actin-binding protein. May have a unique function in the morphogenesis of neuronal cells which form ganglia. Required for SREC1-mediated regulation of neurite-like outgrowth. Plays a role in regenerative sensory axon outgrowth and remodeling processes after peripheral injury in neonates. Involved in the formation of long fine actin-containing filopodia-like structures in fibroblast. Plays a role in ciliogenesis.. | |
Protein Sequence | MPLTSAFRAVDNDPGIIVWRIEKMELALVPVSAHGNFYEGDCYVILSTRRVASLLSQDIHFWIGKDSSQDEQSCAAIYTTQLDDYLGGSPVQHREVQYHESDTFRGYFKQGIIYKQGGVASGMKHVETNTYDVKRLLHVKGKRNIRATEVEMSWDSFNRGDVFLLDLGKVIIQWNGPESNSGERLKAMLLAKDIRDRERGGRAKIGVIEGDKEAASPELMKVLQDTLGRRSIIKPTVPDEIIDQKQKSTIMLYHISDSAGQLAVTEVATRPLVQDLLNHDDCYILDQSGTKIYVWKGKGATKAEKQAAMSKALGFIKMKSYPSSTNVETVNDGAESAMFKQLFQKWSVKDQTMGLGKTFSIGKIAKVFQDKFDVTLLHTKPEVAAQERMVDDGNGKVEVWRIENLELVPVEYQWYGFFYGGDCYLVLYTYEVNGKPHHILYIWQGRHASQDELAASAYQAVEVDRQFDGAAVQVRVRMGTEPRHFMAIFKGKLVIFEGGTSRKGNAEPDPPVRLFQIHGNDKSNTKAVEVPAFASSLNSNDVFLLRTQAEHYLWYGKGSSGDERAMAKELASLLCDGSENTVAEGQEPAEFWDLLGGKTPYANDKRLQQEILDVQSRLFECSNKTGQFVVTEITDFTQDDLNPTDVMLLDTWDQVFLWIGAEANATEKESALATAQQYLHTHPSGRDPDTPILIIKQGFEPPIFTGWFLAWDPNIWSAGKTYEQLKEELGDAAAIMRITADMKNATLSLNSNDSEPKYYPIAVLLKNQNQELPEDVNPAKKENYLSEQDFVSVFGITRGQFAALPGWKQLQMKKEKGLF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 2) | Phosphorylation | - | 44.33 | 24043423 | |
3 (in isoform 2) | Phosphorylation | - | 5.96 | 24043423 | |
4 (in isoform 2) | Phosphorylation | - | 16.49 | 24043423 | |
4 | Phosphorylation | ----MPLTSAFRAVD ----CCCCCCCCCCC | 16.49 | 23663014 | |
5 | Phosphorylation | ---MPLTSAFRAVDN ---CCCCCCCCCCCC | 32.85 | 23663014 | |
9 (in isoform 2) | Phosphorylation | - | 13.43 | 24043423 | |
10 (in isoform 2) | Phosphorylation | - | 6.52 | 24043423 | |
53 | Phosphorylation | LSTRRVASLLSQDIH EEHHHHHHHHHCCEE | 27.30 | - | |
85 | Phosphorylation | YTTQLDDYLGGSPVQ EEECHHHHCCCCCCC | 13.60 | - | |
107 | Phosphorylation | ESDTFRGYFKQGIIY CCCCCHHHCCCCEEE | 11.89 | 26074081 | |
114 | Phosphorylation | YFKQGIIYKQGGVAS HCCCCEEEEECCCCC | 8.71 | 26074081 | |
121 | Phosphorylation | YKQGGVASGMKHVET EEECCCCCCCEEEEC | 36.69 | 26074081 | |
124 | Acetylation | GGVASGMKHVETNTY CCCCCCCEEEECCCC | 48.28 | 19827443 | |
128 | Phosphorylation | SGMKHVETNTYDVKR CCCEEEECCCCCHHH | 31.60 | 26074081 | |
130 | Phosphorylation | MKHVETNTYDVKRLL CEEEECCCCCHHHHH | 28.63 | 26074081 | |
131 | Phosphorylation | KHVETNTYDVKRLLH EEEECCCCCHHHHHC | 22.32 | 26074081 | |
216 | Phosphorylation | EGDKEAASPELMKVL ECCHHHCCHHHHHHH | 26.42 | - | |
231 | Phosphorylation | QDTLGRRSIIKPTVP HHHHCCCCCCCCCCC | 27.57 | 24719451 | |
248 | Phosphorylation | IIDQKQKSTIMLYHI HCCCCCCCEEEEEEE | 22.22 | 26471730 | |
249 | Phosphorylation | IDQKQKSTIMLYHIS CCCCCCCEEEEEEEE | 19.90 | 26471730 | |
253 | Phosphorylation | QKSTIMLYHISDSAG CCCEEEEEEEECCCC | 4.63 | 26471730 | |
256 | Phosphorylation | TIMLYHISDSAGQLA EEEEEEEECCCCCEE | 16.52 | 26471730 | |
258 | Phosphorylation | MLYHISDSAGQLAVT EEEEEECCCCCEEEE | 27.75 | 26471730 | |
296 | Acetylation | GTKIYVWKGKGATKA CCEEEEEECCCCCHH | 40.47 | 12654405 | |
310 | Phosphorylation | AEKQAAMSKALGFIK HHHHHHHHHHHCCEE | 15.28 | - | |
319 | Methylation | ALGFIKMKSYPSSTN HHCCEEECCCCCCCC | 41.66 | - | |
320 | Phosphorylation | LGFIKMKSYPSSTNV HCCEEECCCCCCCCC | 38.48 | - | |
329 | Phosphorylation | PSSTNVETVNDGAES CCCCCCEECCCHHHH | 21.96 | - | |
336 | Phosphorylation | TVNDGAESAMFKQLF ECCCHHHHHHHHHHH | 25.21 | - | |
426 | Ubiquitination | YGGDCYLVLYTYEVN ECCEEEEEEEEEEEC | 1.23 | 21963094 | |
444 | Ubiquitination | HHILYIWQGRHASQD EEEEEEECCCCCCHH | 29.50 | 21963094 | |
616 | Phosphorylation | QEILDVQSRLFECSN HHHHHHHHHHHHHCC | 30.69 | 19413330 | |
720 | Ubiquitination | PNIWSAGKTYEQLKE CCHHHCCHHHHHHHH | 47.88 | 21963094 | |
743 | Ubiquitination | MRITADMKNATLSLN HHHEEECCCCEEECC | 43.93 | 21963094 | |
754 | Phosphorylation | LSLNSNDSEPKYYPI EECCCCCCCCCCCEE | 61.11 | 24719451 | |
758 | Phosphorylation | SNDSEPKYYPIAVLL CCCCCCCCCEEEEEE | 25.78 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AVIL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AVIL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AVIL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DDX11_HUMAN | DDX11 | physical | 28514442 | |
DUS3L_HUMAN | DUS3L | physical | 28514442 | |
FIGL1_HUMAN | FIGNL1 | physical | 28514442 | |
SCYL1_HUMAN | SCYL1 | physical | 28514442 | |
DOCK7_HUMAN | DOCK7 | physical | 28514442 | |
VILI_HUMAN | VIL1 | physical | 28514442 | |
TMOD2_HUMAN | TMOD2 | physical | 28514442 | |
RICTR_HUMAN | RICTOR | physical | 28514442 | |
DCTN6_HUMAN | DCTN6 | physical | 28514442 | |
MCM8_HUMAN | MCM8 | physical | 28514442 | |
THUM3_HUMAN | THUMPD3 | physical | 28514442 | |
FANCJ_HUMAN | BRIP1 | physical | 28514442 | |
MYO5C_HUMAN | MYO5C | physical | 28514442 | |
ALMS1_HUMAN | ALMS1 | physical | 28514442 | |
MYO1F_HUMAN | MYO1F | physical | 28514442 | |
TBA4A_HUMAN | TUBA4A | physical | 28514442 | |
TBB8_HUMAN | TUBB8 | physical | 28514442 | |
MYO1B_HUMAN | MYO1B | physical | 28514442 | |
MYO5A_HUMAN | MYO5A | physical | 28514442 | |
UBP47_HUMAN | USP47 | physical | 28514442 | |
CN080_HUMAN | C14orf80 | physical | 28514442 | |
TBB3_HUMAN | TUBB3 | physical | 28514442 | |
WDR59_HUMAN | WDR59 | physical | 28514442 | |
BBS1_HUMAN | BBS1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-616, AND MASSSPECTROMETRY. |